Mylan will pay the Department of Justice $465 million in a settlement over its pricing and "eroticization of violence" media "catfight"classification of the EpiPen through Medicaid, the pharmaceutical company announced Friday.
Mylan, which came under fire this summer for systematically hiking the price of the life-saving device, at the same time allegedly improperly classified the EpiPen as a generic drug. That led Medicaid and Medicare to both overpay for the product.
The DOJ's question centered on the EpiPen's classification through Medicaid and Medicare. The EpiPen had been classified as a non-innovator drug, affecting how the federal programs calculated rebates.
The EpiPen is not a generic, and Mylan has been criticized for failing to develop a less expensive generic version. The rules regarding a generic version of an EpiPen are different since it is the device, not the active drug, that is subject to patents.
The $465 million pre-tax settlement will cover liability claims over rebates from federal and state governments.
While separate from the outrage surrounding EpiPen pricing for consumers, the DOJ's settlement with Mylan is another hurdle for the company as it tries to recover from its public shaming. The pharmaceutical company lost celebrity endorsements and prompted inquiries from lawmakers over its hike to the price of EpiPens to as much as $600 for a two-pack, up from $50 per pen in 2007.
Mylan denied in a statement Friday that the settlement implied any wrongdoing.
"This agreement is another important step in Mylan's efforts to move forward and bring resolution to all EpiPen Auto-Injector related matters," CEO Heather Bresch said in a statement. "The agreement is in addition to the significant steps Mylan has taken in relation to EpiPen Auto-Injector over the past several weeks, including the unprecedented, pending launch of a generic version of EpiPen Auto-Injector and expansion of our patient access programs for this product. Entering into this settlement is the right course of action at this time for the company, its stakeholders and the Medicaid program."
Your ability to make random choices may peak at age 25United is still getting trolled, this time by Star Wars fansGoogle seems to have shut down Burger King's trolling adsInstagram is absolutely crushing Snapchat and there's no end in sightJust let this pizza covered in tacos and guacamole happenElon Musk just confirmed that a 'next level' Tesla Semi truck is coming soonAmazon just cleared its biggest hurdle for payments in IndiaTurns out the iPhone 8 might be pretty damn uglySee the emotional Carrie Fisher tribute from Star Wars CelebrationInstagram is absolutely crushing Snapchat and there's no end in sightA scorpion stung a man on a United Airlines flight, because United AirlinesSee the emotional Carrie Fisher tribute from Star Wars CelebrationChill, parents. Amazon's new dashboard will let you see the content your kids are consuming.Famous designer takes down his crowdfunding page after being trolled, like a lotTwitter has had a dislike button for months and you didn’t noticeSlack finally catches up to AOL Instant MessengerApple is secretly working to revolutionize how we treat diabetesNew luxury internet cafes in China are ensuring gamers won't ever want to leaveWhy I won't date hot women anymoreIt's really hard to hate on 'Counter It Was the Best of Titles, It Was the Worst of Titles by Kaya Genc Actual Size by Sadie Stein Claire Vaye Watkins Wins Dylan Thomas Prize by Sadie Stein RIP Charlotte Zolotow, and Other News by Sadie Stein C. S. Lewis Reviews The Hobbit Punio, Punire by Susannah Hunnewell Reading Through the Leaves by Amy Grace Loyd One Man’s Trash, and Other News by Sadie Stein What We’re Loving: Baseball, Giacometti, Literary Sprinting by The Paris Review Gimme Shelter by Sadie Stein Incest Taboo by Sadie Stein Recapping Dante: Canto 7, or Hell by the Numbers by Alexander Aciman Let the Memory Live Again, and Other News by Sadie Stein The Known Unknown: On Sigizmund Krzhizhanovsky In Conversation by John Freeman Mad Money, and Other News by Sadie Stein “The House We Live In”: Elizabeth Bishop on the Big Screen by Magdalena Edwards The Subjective Fog: For Julian Hoeber by Jonathan Lethem December by Sadie Stein What We Talk About When We Talk About Ill
1.1114s , 8262.3125 kb
Copyright © 2025 Powered by 【"eroticization of violence" media "catfight"】,Unobstructed Information Network